LAUREN AGEE: Open Payments
NPI 1952927493 · CANTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,317 in 61 payments from 26 companies in 2025. Trend: 2023 $19 · 2024 $1,770 · 2025 $1,317
Food & beverage: $1,301Education: $16
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $260 |
| Janssen Biotech, Inc. | 6 | $164 |
| AstraZeneca Pharmaceuticals LP | 3 | $80 |
| Celgene Corporation | 3 | $73 |
| Exelixis Inc. | 3 | $70 |
| Gilead Sciences, Inc. | 3 | $66 |
| GENZYME CORPORATION | 3 | $62 |
| GlaxoSmithKline, LLC. | 2 | $60 |
| Caris MPI, Inc. | 3 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $54 |
Products named: IBRANCE, REBLOZYL, CABOMETYX, Trodelvy, TALVEY, SARCLISA, JEMPERLI, ERLEADA.
Industry payments across GA — which companies pay providers there.
